Popular Articles

Merck Issues Statement On WHO Study Showing First Evidence That Elimination Of River Blindness Is Feasible In Africa
Merck & Co., Inc. issued the following statement in response to study results published today by the World Health Organization offering the first evidence that elimination of the tropical disease river blindness (onchocerciasis) in Africa is feasible with treatment with ivermectin (registered trademark Mectizan®). As the discoverer and manufacturer of Mectizan, Merck decided in 1987 to donate the drug to all who need it for as long as necessary until river blindness is eliminated as a public health problem. The Merck Mectizan Donation Program is one of the longest-running disease-specific drug donation and public/private partnership programs in history.
generic viagra online
New Avatar Technology Combines Advances In Artificial Intelligence And Computer Image Rendering
Have you ever wished you could be in two places at once? Perhaps you"ve had the desire to create a copy of yourself that could stand in for you at a meeting, freeing you up to work on more pressing matters. Thanks to a research project called LifeLike, that fantasy might be a little closer to reality.
News of the day
New Pheromone Helps Female Flies Tell Suitors To 'buzz Off'
There she is again: the cute girl at the mall. Big eyes. Long legs. She smiles at you. You"re about to make your moveň€¦ but wait! What"s she wearing? It"s a letterman jacket, one clearly belonging to a hulking football player named "Steve." This girl is taken. Wisely, you move on.
Public Health

States Consider Scaling Back Funding For Medicare Drug Benefit Amid Economic Crisis

At least six states have considered eliminating or reducing financial assistance for those enrolled in the Medicare prescription drug benefit program who are affected by the "doughnut hole," or gap in coverage, the AP/Boston Herald reports. According to the AP/Herald, the governors of Rhode Island and Vermont and lawmakers in South Carolina have proposed plans to eliminate such financial assistance programs, while Massachusetts has reduced funding for its program. Meanwhile, proposals in New York and Connecticut to limit financial help have been dismissed.Beneficiaries enrolled in the drug benefit have coverage until total spending reaches $2,700 and then must pay out-of-pocket for their medications until the total spending reaches $4,350, after coverage. At least 16 states provide financial help to beneficiaries who have reached the coverage gap (AP/Boston Herald, 5/27). Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):